JPRN-UMIN000016728
Recruiting
Phase 2
Efficacy and safety of nab-paclitaxel plus carboplatin in patients with Carcinoma of unknown primary site - Efficacy and safety of CBDCA plus nab-PTX in patients with CUP
Teikyo University School of Medicine0 sites30 target enrollmentMarch 6, 2015
ConditionsCarinoma of unknown primary site(CUP)
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Carinoma of unknown primary site(CUP)
- Sponsor
- Teikyo University School of Medicine
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Indication for radical operation and radiotherapy. 2\)Patients unable to take nab\-paclitaxel and CBDCA because of significant cardiovascular abnormalities, renal dysfunctions, hepatic insufficiency, uncontrolled diabetes, uncontrolled hypertension, bleeding tendency, active interstitial pneumonia,etc. 3\)Known active brain metastasis. 4\)Acute or subacute idiopathic interstitial pneumonia 5\)Patient received a bone\-marrow transplantation 6\)Patient received a peripheral stem cell transplantation 7\)Known hypersensitivity to any drugs 8\)Seropositivity for HBsAg 9\)Pregnancy or breast feeding.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
The safety and efficacy trial of nab-paclitaxel and trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancerHER2-positive breast cancerJPRN-UMIN000012798Tokyo Medical University Ibaraki Medical Center35
Recruiting
Phase 2
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22
Recruiting
Phase 1
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
Recruiting
Not Applicable
Safety and efficacy of nab-paclitaxel plus gemcitabine in the patients with recurrent pancreatic cancer after pancreatectomypancreatic cancerJPRN-UMIN000031203niversity of Yamanashi30
Completed
Phase 2
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90